Atlas Trials

Study of ANAVEX2-73 in Patients With Rett Syndrome

Clinical trial NCT03758924 · COMPLETED

Trial details

NCT number
NCT03758924
Sponsor
Anavex Life Sciences Corp.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rett Syndrome
Start date
2019-02-28
Primary completion
2020-10-30
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.